One Fallopian Tube Blocked on HSG: When to Repeat Testing or Choose IUI Versus IVF

A hysterosalpingogram, or HSG, uses contrast imaging to help assess the uterine cavity and whether contrast passes through each fallopian tube. It is one part of a fertility evaluation, not a direct measurement of egg quality or a complete map of pelvic adhesions. Reports may describe proximal occlusion near the uterus, distal obstruction farther along the tube or delayed spill.

Apparent blockage close to the uterus may sometimes be associated with temporary spasm or technical features of the procedure. This does not mean it should always be ignored or that another test is automatically necessary. The clinician can review image quality and consider a targeted method of confirming tubal patency if it would alter treatment decisions. Repeating painful imaging without a purpose may add cost and anxiety.

If one tube is demonstrably patent, some patients may still consider attempts at conception or IUI, depending on age, ovulation and male fertility results. A patent tube is not a guarantee of natural pregnancy, and the side of ovulation does not create a simple monthly success rule. Discuss the duration of infertility, previous treatment attempts and any other diagnosis before choosing a pathway.

An abnormal distal tube, especially when a fluid-filled hydrosalpinx is suspected, requires a different conversation from an uncertain proximal occlusion. The finding may affect both the approach to treatment and planning before embryo transfer. Ultrasound, additional imaging or surgical assessment might be considered where clinically warranted. Never assume that removal of a tube is mandatory from one ambiguous report; invasive decisions require confirmed findings, individual consent and consideration of the other tube and ovarian reserve.

An IUI decision requires more than an HSG result. The responsible clinician should review semen analysis, ovulation, age, ovarian reserve where useful, duration of infertility and whether the remaining tube is usable. IVF bypasses the need for fertilization inside the fallopian tubes, but still involves medication, monitoring, egg retrieval, embryology and embryo transfer in appropriate facilities. Request itemized quotes for the alternatives and ask what further evidence could change the recommendation.

Keep the image or radiology report, previous pelvic scans, operative notes if relevant, results of infection investigations when clinically indicated, semen analyses and a timeline of attempts. State whether there has been pelvic inflammatory disease, ectopic pregnancy or prior abdominal surgery. A second opinion is most useful when it addresses the actual location and certainty of blockage, not when it simply repeats a generic IVF sales pitch.

Putting the decision together. Start by asking what would be different if the answer to “what an hsg actually shows?” changed. Then compare that with “distal disease and hydrosalpinx are separate concerns?” in the actual medical record. These questions should lead to a clear choice: proceed with the current plan, obtain a targeted missing result, consider a clinically appropriate alternative, or pause for specialist review. They should not become a standing order for every available fertility test. The clinician should document any uncertainty that remains, because good care is not the same as claiming complete predictability.

Two patients searching for the same term may need very different care. One may require focused diagnostic clarification while another already has enough information to decide between treatment options. The clinician should state the expected benefit of every proposed step and what alternative exists. Records from previous cycles often answer more questions than buying a new panel of tests simply because the old provider used a different name for it.

HomeIVF is a doctor-led model for fertility and IVF care that aims to reduce unnecessary clinic visits, not a way to perform IVF laboratory procedures inside a home. Where a responsible clinician judges it suitable and the actual address is supported, a teleconsultation, selected home blood collection or supervised injection assistance may be arranged. Availability, collection timing, staff qualifications and charges must be confirmed rather than assumed. Medically indicated ultrasound scans, egg retrieval, IUI procedures, sperm preparation, embryo culture, genetic testing and embryo transfer remain facility-based. The clinician supervising treatment must be able to respond to results and complications.

Before accepting a remote-care plan, ask the treating clinician to identify each event that requires in-person assessment. This may change between cycles as scan results, ovarian response or symptoms change. Some steps can be coordinated by telephone or video, but procedure-day decisions belong to the appropriately equipped fertility team. Written consent and a transparent escalation route make flexible care safer.

Choose the next step by asking whether it is necessary now, what evidence supports it and what happens if it is deferred. Treatment estimates can change when stimulation response, test results or laboratory findings differ from expectations. Confirm refund, cancellation and storage policies before payment. Most importantly, do not interpret a low advertised price as evidence of quality, or a high price as a guarantee.